Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences

Theme
Fostering the future excellence in Cardiology and Cardiovascular Medicine
- Global Cardiology Congress 2019

Welcome Message


About Global Cardiology Congress 2019

Global Cardiology Congress 2019 Conference will be an examination of new research Innovation in the field of Cardiology and spread the latest progressions in heart disease prevention and recovery. Discussion on new technology advancement in the field of Cardiovascular Disease, current practices in cardiovascular therapy, Heart Disease Management, Stem cell Research on heart, Silent ischemia and ischemic heart disease, Heart failure, Congestive heart failure and more. Detecting heart disease and other cardiac conditions involves a team of healthcare professionals, of which the Cardiology technologist is a key player. The global cardiology market is expected to grow at a strong CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,100 million by 2019. The market is mainly driven by the increasing research funding for cardiology from governments and private investors, growing demand for personalized medicine in the U.S. and Europe.

                                                           


Why to attend Global Cardiology Congress 2019????

With people from around the world focused on getting some answers concerning Cardiology, this is your single most obvious opportunity to accomplish the greatest accumulation of individuals from the mending focuses, Universities, bunch, etc. These Global Cardiology Congress in 2019 will coordinate appear; disperse information, meeting with recurring pattern and potential investigators and get name affirmation at this 2-day event. Broadly acclaimed speakers, the most recent frameworks, methodologies, and the most current updates in Cardiology field are indications of this conference. This Global Cardiology Congress, Cardiology Gatherings, Cardiology events and Cardiology Meetings will help in frameworks organization, B2B uniting amidst specialists, Perfusionists and academicians.


This Global Cardiology Congress will be a truly international event; we expect to welcome healthcare professionals from over 100 countries. We also have a global faculty who are leading experts in their fields. Gain valuable awareness from these prominent professionals from skilled institutions. 


Registration Benefits:

  • CME (Continuing Medical Education) Credits
  • All 2 days programs
  • Reception banquet
  • B2B meetings
  • A free paper abstract in our Journal for free of cost
  • Accepted Abstracts will be published in respective supporting journals, each abstract will be labelled with a DOI provided by Cross Ref.
  • Certificate of the presentation by International Organizing Committee (IOCM)
  • Can attend all the Interactive sessions and Workshops
  • Career Guidance Workshops to the Graduates, Doctorates and Post-Doctoral Fellows
  • 2 days Lunch during the conference
  • Coffee break during the conference
  • Conference Kit
  • Acknowledged modified works will be distributed in specified journals with DOI.
  • Ecumenical systems administration: In exchanging and trading Conceptions.
  • Master Forums.
  • Best Poster Awards.
  • Best Start-Up Awards.
  • Pre-conference and Conference Workshops.
  • Symposiums on Latest Research.

Discounts are available on Group Registrations

20% discount available on a group of 10+ members

To register for Global Cardiology Congress 2019: Click here

           

Sessions/Tracks

Cardiovascular diseases, including congestive heart failure, hypertension, atherosclerosis, stroke, aneurysms, and vascular auto-immune diseases are the most common cause of death and disability. Cardiovascular Research is to support interdisciplinary research in basic, translational and clinical cardiovascular sciences, including cardiovascular development, function, pathophysiology, pharmacology, genetics, genomics, and proteomics to apply this knowledge to better understand the causes of cardiovascular diseases and to pioneer development of new innovative therapies and approaches to prevent or treat.



Cardiac Pharmacology deals with the study of the effect of drugs upon the heart or the circulatory system. Cardiovascular diseases are a leading cause of hospitalizations and death in the entire world. Developing new therapeutic agents for cardiovascular diseases has always been the priority for the pharmaceutical industry because of the huge potential market for these drugs. Cardiovascular Pharmacology and Therapeutics will focus primarily on drugs used in the treatment of cardiovascular disease, both current drug classes and those in development. It mainly contributes to the safety profile of potential new drugs and provides pharmacological data that can be used for optimization of further compounds and the ultimate selection of compounds suitable for clinical development.



Cardiac surgery is an invasive method used for the correction of certain disorders/defects caused to the heart. This surgery is done only by cardiac surgeons and helps in the correction of ailments caused, if the patient is suffering from blood clot then the doctors commence an open heart surgery wherein the clot is either removed and a stent is placed or the clot is removed using angioplasty method. In this method, the need for open heart surgery is not required with minimal loss of blood and with the help of catheters the clot is removed thus helping the heart function to be in stable condition. Also for various types of valve replacements and for implantation in the heart, cardiac surgeries are carried out.

  • Open Heart Surgery
  • Heart Valve Replacement
  • Ballon Angioplasty
  • Cardiomyoplasty
  • Septal Myectomy
  • Advances in congenital heart disease
  • Angioplasty or surgery for multi vessel coronary artery disease
  • New approaches to surgical revascularization: Minimally invasive surgery, TMLR
  • Therapeutic and physiologic issues surrounding heart valve surgery
  • Mechanical support left ventricular assist devices
  • Surgery for LV dysfunction




Cardiovascular Nurses work in many different environments, including coronary care units (CCUs), cardiac catheterization, intensive care units (ICUs), operating theatres, heart rehabilitation centers, clinical research, cardiac surgery departments, and cardiovascular intensive care units. Cardiac nursing is a special nursing field which works with patients who suffer from different conditions of the cardiovascular system. Cardiac nurses help treat and care conditions such as unstable angina, cardiomyopathy, coronary artery disease, congestive heart failure, infarction of myocardium and cardiac arrhythmia under the direction of a cardiologist. Cardiac nurses perform post-operative treatment on a surgical unit, stress test evaluations, cardiac monitoring, vascular monitoring, and health evaluations. Cardiac nurses work in various kinds of environments, involving coronary care units (CCU), catheterization of heart, intensive care units (ICU), operating theatres, cardiac rehabilitation Centers, clinical research, wards for cardiac surgery, cardiovascular intensive care units (CVICU), and cardiac medical wards.



Obesity can also lead to heart failure. This is a serious condition when your heart cannot pump enough blood to satisfy the needs of your body. After affected by diabetes, a person is at increased risk of heart disease and stroke. One can reduce the risk by maintaining blood glucose levels, blood pressure and blood cholesterol levels close to the recommended target values - levels suggested by diabetes professionals for good health. Stroke and coronary heart disease can be caused by the same problem - atherosclerosis.The term "diabetic heart disease" (DHD) means heart disease that occurs in people who have high content of carbohydrate in blood. In comparison with people who don't have diabetes, people who have diabetes; are at a higher risk of heart disease, have additional reasons of heart disease, may develop heart disease at a younger age, may have more severe heart diseases. In Congenital Heart Disease, a waxy substance called plaque builds up inside the coronary arteries. These arteries supply our heart muscle with blood rich in oxygen. Plaque constitutes of fat, cholesterol, calcium, and various other substances found in the blood. When plaque happens in the arteries, the condition is called atherosclerosis.
  • Diabetic cardiomyopathy
  • Hypertension
  • Abnormal cholesterol and high triglycerides
  • Pre-diabetes
  • Types of strokes




People who have severe heart failure or serious arrhythmias (irregular heartbeats) are candidates for implantable defibrillators. These devices are surgically placed and deliver pacing, or an electric counter shock, to the heart when a life-threatening abnormal rhythm is detected. People with heart failure develop abnormal conduction of the heart’s electrical system that changes how efficiently the heart beats. Cardiac resynchronization therapy, also known as biventricular pacing, may be needed. The left ventricle is the large, muscular chamber of the heart that pumps blood out to the body. A left ventricular assist device (LVAD) is a battery-operated, mechanical pump-type device that's surgically implanted. Heart failure can develop when blockages in the coronary arteries restrict the blood supply to the heart muscle. Removing these blockages can improve overall heart function, which may improve or resolve heart failure symptoms. PCI is one type of procedure to reopen blocked vessels. Coronary artery bypass surgery reroutes the blood supply around a blocked section of the artery. During this procedure, surgeons remove healthy blood vessels from another part of the body, such as a leg or the chest wall. They then surgically attach the vessels to the diseased artery in such a way that the blood can flow around the blocked section.

  • Cardiac resynchronization therapy
  • Defibrillation technology
  • Cardiac pacemaker
  • LV reverses remodeling
  • Defibrillator
  • Pacemaker
  • Intra-aortic balloon pump (IABP)


Cardiac diagnostic tests are being discovered to understand the disease, injury, and congenital (present at birth) and other acquired abnormalities of the heart. Few diagnostic tests like Electrocardiogram (ECG), Stress test (also called tread mill or exercise ECG), Transesophageal echocardiogram, Holter monitor and Loop recorder are used to visualise the damaged heart tissues and blood vessels in cardiovascular diseases. In Electro physiology study, the irregular heart rhythms are examined by fixing the insulated electric catheters in the large vein of the upper leg and thread into the heart. The other test like Tilt Table test, involves the patient being placed in a table with foot support and table is tilted upward and downwards and the patient’s blood pressure, heart beat and pulse rate are monitored throughout during the process. Cardiology diagnostic tests are the methods of identify the heart conditions associated with pathologic heart function.
  • Biochemical markers of acute ischemia
  • Transesophageal echocardiography
  • Pharmacologic stress testing - echocardiography
  • Echocardiography, three-dimensional reconstruction
  • Nuclear cardiology - new techniques to assess cardiac perfusion, function and viability
  • PET - new insights into myocardial metabolism
  • Applications of cardiac magnetic resonance imaging
  • CT and coronary calcification
  • Percutaneous coronary angioscopy
  • Intravascular ultrasound imaging
  • Intracoronary flow, Doppler measurements


Track 8: Cardiomyopathy and Heart Failure
Cardiomyopathy is a condition where the heart muscle is not normal. Dilated, Hypertrophic and Restrictive cardiomyopathy are the main types of cardiomyopathies. This condition makes it harder for the heart to pump and deliver blood to the rest of the body. Coronary heart disease can lead to heart failure by weakening the heart muscle over time. The term heart failure doesn't mean that the heart has stopped or is about to stop working. It is a serious condition that requires medical care.

  • Sudden cardiac arrest
  • Myocardial infraction and repair
  • Congestive heart failure
  • Neurohumoral, immunologic and cytokine aspects of heart failure
  • Nitric oxide and nitric oxide synthase in heart failure
  • Myocyte and receptor abnormalities in heart failure
  • Natriuretic peptides, endothelin: role in heart failure
  • Inflammatory mediators and heart failure
  • Dilated cardiomyopathy: various etiologies
  • Ischemic cardiomyopathy
  • Left ventricular hypertrophy and hypertrophic cardiomyopathy
  • Role of the pericardium, pericarditis and restrictive cardiomyopathy
  • Pathophysiologic and prognostic insights in valvular heart disease
  • Pulmonary circulation aspects, pulmonary hypertension
  • Predictors and markers of heart failure outcome
  • Exercise physiology in heart failure
  • Renal aspects - diuretics
  • Digoxin and other new inotropic agents in heart failure
  • ACE inhibitors and Angiotensin-ll receptor blockers
  • Beta-blockers and beta-adrenergic receptors in heart failure
  • Calcium channel blockers and promoters in heart failure
  • Cardiac pacing strategies in heart failure


Related Associations: Ontario Association of Cardiologists, Canada | North American Society For Cardiology, USA | Texas Cardiology Associates of Houston, USA | Egyptian Association For Heart Disease, Egypt | Canadian Pediatric Cardiology Association, USA | Cardiac Association of New Zealand, New Zealand | Canadian Association of  Cardiovascular Prevention and  Rehabilitation, UK

Related Societies:
Northwest Association of Cardiovascular and Pulmonary Rehabilitation, USA | Philippine Heart Association, Philippines | Society for Cardiovascular Angiography and Interventions, USA | Spanish Society of Cardiology, Spain | The American Society for Preventive Cardiology, USA | The British Cardiovascular Society, UK | World Heart Failure Society, Netherlands | World Heart Federation, Switzerland

In human embryos the heart begins to beat at about 22-23 days, with blood flow beginning in the 4th week. The heart is therefore one of the earliest differentiating and functioning organs.The heart begins very early in mesoderm within the trilaminar embryonic disc. The heart forms initially in the embryonic disc as a simple paired tube inside the forming pericardial cavity, which when the disc folds, gets carried into the correct anatomical position in the chest cavity.

A key aspect of heart development is the septation of the heart into separate chambers. As the embryonic or fetal circulation is different to the neonatal circulation, several defects of heart septation may only become apparent on this transition. One septal "defect" occurs in us all, the foramen ovale (between the 2 atria) which in general closes in the neonate over time.
Embryonic Heart Rate (EHR), early in development the heart starts to spontaneously beat and a recent study by Wisser and Dirschedl in dated human embryos showed an increase up to 63 postmenstrual days or 22 mm greatest length. Thereafter a steady decrease of EHR was noted. Maximal EHR is reached when morphological development of the embryonic heart is completed.

The cardiovascular system consists of the heart, blood, and blood vessels (arteries, veins, and capillaries).  This complex system is involved in a diverse number of functions, including: Transporting blood, proteins, nutrients, O2, CO2, and other molecules, Tissue regeneration and reorganization, Developmental processes, Thermoregulation, Immune response, Wound healing




Track 10: Hypertension
Hypertension is another name for high blood pressure. It’s a disease that can lead to severe complications and increases the risk of heart disease, stroke, and death. Blood pressure can be defined as the force exerted by the blood against the walls of the blood vessels and the pressure depends on the work being done by the heart and the resistance of the blood vessels. Medical guidelines define hypertension as a blood pressure higher than 130 over 80 millimetres of mercury (mmHg), according to guidelines issued by the American Heart Association (AHA) in November 2017. Around 85 million people in the United States are suffering from high blood pressure. Hypertension and heart disease are the leading global health concerns. The World Health Organization (WHO) suggests that the growth of the processed food industry has impacted the amount of salt in diets worldwide, and that plays a role in hypertension.
  • Hypertension & heart disease
  • Pulmonary hypertension
  • Hypertension risk factors
  • Pharmacological treatments for hypertension



Interventional cardiology is the part of cardiology that holds with the definite Cather based techniques to many structural heart diseases, non-surgical actions for treating cardiovascular infections. Often, to remove the need for surgery a thin, elastic tube known as catheter which is used to repair infectious vessels or other heart structures diseases. In addition, for an acute myocardial infarction the actions includes in interventional cardiology for doing as a best standard of care. It involves in rejection of clots from coronary arteries and implementation of stents and balloons from a small hole made in a major artery. Coronary intervention is usually the dominant procedure for the interventional cardiologist, which moves to the development of new actions in upcoming decade in proportional to the population growth. It is seen that interventional cardiology craves a newly attention in the increase of valvular heart infection intervention.

  • Coronary Stents
  • Embolic protection
  • Percutaneous valve repair
  • Angioplasty
  • Balloon valvuloplasty
  • Embolic protection
  • Atherectomy
  • Cardiac catheterization



An inborn issue otherwise known as an innate illness, distortion, birth deformity, or inconsistency, may be a condition existing at or before birth paying very little heed to evoke. Birth surrenders fluctuate typically in cause and aspect effects. Some intrinsic heart diseases in youngsters are easy and needn't hassle with treatment, as an instance, a bit gap between heart chambers that closes on their lonesome. Alternative intrinsic heart abandons in youngsters are a lot of Byzantine and should need a couple of surgeries performed over a time of quite long whereas, the rationale for an inborn heart deformity is often unknown. Having a guardian with innate heart imperfectness is likewise a danger issue. Variety of hereditary conditions are connected with heart absconds as well as Down disorder, Turner disorder, and Marfan syndrome. No heritable heart imperfections are isolated into 2 principle branches:
  • Cyanotic heart abandons
  • Non-cyanotic heart diseases



A case report on Cardiology gives an appropriate convention for all cardiologists by rendering their important clinical cases of late occurrence. Studying from medical cases provides valuable experience for clinicians, students and paramedical staff -members. Rare medical reports and conditions discovered through the latest methods of examination are energized. Moreover, studying diagnostic methods from medical cases and the interpretation of symptoms is significant to train and burgeon the thought processes which are being used in the clinical field.


Market Analysis

The cardiovascular disease market, which includes various numbers of disorders like hypertension, coronary artery disorders, cardiac arrest, dyslipidaemia and thrombotic events, is set to grow from $129.2 billion in 2015 to $146.4 billion by 2022, at a very modest compound annual growth rate of 1.8%, according to business intelligence provider GBI Research.

 

‘Novartis’ heart-failure drug Entresto was introduced to the market in July 2015, and GBI Research expects its revenues to increase dramatically during the forecast period. Entresto is a combination drug, which has shown efficacy in clinical trials. Coupled with a high cost, which amounts to over $4 500 annually per patient, the drug contributes to a very high revenue forecast of $5.7 billion by 2022.

 

The sheer number of expirations and approvals means the structure of the market will shift significantly. According to the registry of the International Society for Heart and Lung Transplantation, approximately 500-600 pediatric heart transplantation procedures are performed globally every year, which represents around 12% of the total number of heart transplants performed among all the patients. And in 2014, a total number of pediatric heart transplants execute globally was 586. In children, the most often caused of heart failure is occurred owing to a congenital heart defect or a cardiomyopathy. Thus this increasing rate of heart failure has increased the fatality rate in children with this disorder.

 

The global market for a heart transplant is expected to grow at a CAGR (Compound Annual Growth Rate) of 11.2% during the forecast period of 2017-2023. The global Interventional Cardiology market is anticipated to grow at a steady rate and will post a CAGR of more than 7% during the forecast period. The growing demand for minimally invasive (MI) procedures will drive the growth prospects for the global Interventional Cardiology market in the forthcoming years.

 

Various countries have gained a high-profit margin due to cardiology disorders and have continued their research for the development and proper cure of all kind of heart disorders with new innovations and discoveries.

 

Scope and Importance

 

Cardiology is an ever-developing branch in the field of medicine. People in this era both young and old are vulnerable to heart disorders which are mainly due to their lifestyle and improper hygiene. In order to tackle these diseases and its causes, the study of Cardiology has gained high importance in the course of time. Interventional cardiology is a part of cardiology which uses minimally invasive methods to correct disorders with the use of a catheter which helps doctors and patients to have the surgery done with less blood loss and minimal risk.

Why Dublin, Ireland?

Dublin voted as Europe’s fourth most popular city break destination, behind London, Paris and Rome and is also one of the friendliest capital cities in the World. Dublin’s elegant Georgian architecture makes it one of Europe’s most attractive capitals.

Also considered to be a relatively small accessible city, small enough with safe enough to get around on foot, whereas the Lucas tram system with the rail system, the DART, provide excellent featured transport links which stays best throughout the city. We can find many of the nation’s treasures, housed in the city’s galleries and the famous museums where some of the most important events of Ireland were played out, most important events of Ireland were played out, most notably the Easter Uprising of 1916. Though the battle between the IRA and British Forces caused extensive damage to the O’Connell Street area of Dublin, (the bullet holes can still be seen on the General Post office) this was one of the formative events of the Irish Republic.

Target Audience:



Probability of Cardiovascular Diseases:



Organizing Committee
OCM Member
Maria Amparo Lopez-Ruiz
Head of the Advanced Simulation Center, Faculty of Health
CEU Cardenal Herrera University
Valencia, Spain
OCM Member
Lin Wu
Professor and Chief Physician , Cardiology
Peking University First Hospital
Beijing, China
OCM Member
Miguel Angel Maluf
Professor, Cardiovascular
Federal University of São Paulo (UNIFESP)
Brazil city, Brazil
OCM Member
Juan C Manrique Arias
Faculty of Medicine, Cancerology Cyclotron and Radiopharmacy
National Autonomous University of Mexico School of Medicine
Mexico, Mexico
OCM Member
Sibel Catirli Enar
Department of Cardiology
Istanbul University
Istanbul, Turkey
OCM Member
Adarsh Kumar
GND Hospital and Medical College Amritsar
New Delhi, India
OCM Member
Sergey Suchkov
Director, Personalized Medicine
Russian Academy of Sciences, Saratov
Moscow, Russia
OCM Member
Abdullah A Alabdulgader
Founder
Prince Sultan Cardiac Centre
Riyadh, Saudi Arabia
Renowned Speakers

To Collaborate Scientific Professionals around the World

Conference Date June 19-20, 2019
Speaker Oppurtunity Day 1 Day 2
Poster Oppurtunity Available
e-Poster Oppurtunity Available
Sponsorship Opportunities Click here for Sponsorship Opportunities
Venue
&
Hospitality

Venue: Maldron Hotel Newlands Cross, Dublin, Ireland

Registration Benefits:

Only Registration Includes:

  • CME (Continuing Medical Education) Credits
  • Access to All Sessions
  • Coffee break during the conference
  • 2 days Lunch during the conference
  • Handbook & Conference Kit
  • Certificate of Presentation
  • B2B meetings

Package A

  • Accommodation for 2 nights: June 18 &19, 2019
  • Above all only registration benefits

Package B

  • Accommodation for 3 nights: June 18, 19 &20, 2019
  • Above all only registration benefits

Book your Accommodation Now 

Click here for Registration 

For Discounts & Group registration
Contact: Olivia Nicole 
(Program Manager)
globalcardiology@alliedscholars.net

Join The Discussion

Allied Academies Global Conference Directory

Mail us at

Program Enquiry
globalcardiology@alliedannualmeet.com
Sponsor | Exhibitor | Advertise
globalcardiology@alliedannualmeet.net
General Enquiry
olivia.nicole@alliedscholars.com
More details about sponsorship:sponsors@alliedacademies.com

Terms and Conditions

Responsibility:

The organizers holds no responsibilities or liabilities of the personal articles of attendees at the venue against any kind of theft, lost, damage, due to any reason whatsoever. Delegates are entirely responsible for the safety of their own belongings.

 

Insurance:

No insurance, of any kind, is included along with the registration in any of the events of the organization.

 

Transportation:

Please note that transportation and parking is the responsibility of the registrant, Allied Academies will not be liable for any actions howsoever related to transportation and parking.

 

Press/Media:

Press permission must be obtained from Allied Academies Conference Organizing Committee prior to the event. The press will not quote speakers or delegates unless they have obtained their approval in writing. The Allied Academies is an objective third-party non-profit organization and this conference is not associated with any commercial meeting company.

 

Requesting an Invitation Letter:

For security purposes, letter of invitation will be sent only to those individuals who had registered for the conference after payment of complete registration fee. Once registration is complete, please contact globalcardiology@alliedscholars.net to request for a personalized letter of invitation, if not received until one month before the scheduled date of event.

All the bank charges applicable during refund will be deducted from the account of participant.

 

Cancellation Policy:

All cancellations or modifications of registration must be made in writing to finance@alliedacademies.com
 

If, due to any reason, Allied academies postpone an event on the scheduled date, the participant is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

 

Postponement of event:

If, due to any reason, Allied academies postpone an event and the participant is unable or unwilling to attend the conference on rescheduled dates, he/she is eligible for a credit of 100% of the registration fee paid. This credit shall only be used for another event organized by Allied academies within period of one year from the date of rescheduling.

 

Transfer of registration:

All registrations, after payment of complete registration fee, are transferable to other persons from the same organization, if in case the person is unable to attend the event. Request for transfer of registration must be made by the registered person in writing to finance@alliedacademies.com. Details must include the full name of replaced new registrant, their title, contact phone number and email address. All other registration details will be assigned to the new person unless otherwise specified.

 

Registration can be transferred to one conference to another conference of Allied academies if the person is unable to attend one of conferences.

However, Registration cannot be transferred if intimated within 14 days of respective conference.

The transferred registrations will not be eligible for Refund.


Visa Information:

Keeping in view of increased security measures, we would like to request all the participants to apply for Visa as soon as possible.

Allied academies will not directly contact embassies and consulates on behalf of visa applicants. All delegates or invitees should apply for Business Visa only.

Important note for failed visa applications: Visa issues are not covered under the cancellation policy of Allied academies, including the inability to obtain a visa.

 

Refund Policy:

If the registrant is unable to attend, and is not in a position to transfer his/her participation to another person or event, then the following refund policies apply:

 

Keeping in view of advance payments towards Venue, Printing, Shipping, Hotels and other overhead charges, following Refund Policy Orders are available:

Before 60 days of the conference: Eligible for Full Refund after deduction of $100 towards service Fee.

Within 60-30 days of Conference: Eligible for 50% of payment Refund

Within 30 days of Conference: Not eligible for Refund

E-Poster Payments will not be refunded.

Accommodation Cancellation Policy:
Accommodation Service Providers (Hotels) have their own cancellation policies which are applicable when cancellations are made less than 30 days prior to arrival. If in case the registrant wishes to cancel or amend the accommodation, he/ she is expected to inform the organizing authorities on a prior basis. Allied academies will advise the registrant to ensure complete awareness about the cancellation policy of your accommodation provider, prior to cancellation or modification of their booking.

 

Authorization Policy

Copyright © 2019-2020 Allied Academies, All Rights Reserved.